Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iltamiocel for Fecal Incontinence
NCT01600755Phase 2Completed
- Sponsor
- Cook MyoSite
- Start
- Mar 2013
- Primary completion
- Oct 2021
- Modality
- Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of AMDC-USR in fecal incontinence (FI), sponsored by Cook MyoSite. Started Mar 2013; status: completed.
02
Drugs
AMDC-USR
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT01600755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600755.